HomeHealthcare & Life SciencesPharmaceuticals Peutz Jeghers Syndrome Market

United States Peutz Jeghers Syndrome Market Size & Outlook, 2026-2034


United States Peutz Jeghers Syndrome Market Insights

  • As per Reed Intelligence insights, the United States Peutz Jeghers Syndrome Market stood at USD 350.84 Million in 2025 and is anticipated to grow to USD 748.73 Million by 2034.
  • The United States market is expected to advance at a CAGR of 8.81% from 2026 through 2034.
  • In 2025, Genetic Testing accounted for the highest share of the Diagnosis Type market size.
  • During the forecast period, Biomarker-Based Diagnostics is set to register the highest growth, making it the most lucrative Diagnosis Type segment.

Other Key Findings


  • In 2025, United States represented 27.41% of the overall global Peutz Jeghers Syndrome Market size.
  • United States is projected to lead the global Peutz Jeghers Syndrome Market size by 2034.
  • Across North America, United States is anticipated to hold the dominant position in market size by 2034.
  • United States is forecasted to expand at the fastest pace in North America, attaining USD 750.12 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 350.84 Million
Market Size In 2034 USD 748.73 Million
Largest segment Genetic Testing
Units Revenue in USD Million
CAGR 8.81% (2026-2034)
Segmnetation Covered
Diagnosis Type
  1. Genetic Testing
  2. Imaging Techniques
  3. Biomarker-Based Diagnostics
Treatment Type
  1. Surveillance Endoscopy
  2. Surgical Intervention
  3. Targeted Therapy
End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Diagnostic Centers
Distribution Channel
  1. Direct Sales
  2. Online Channels
  3. Third-Party Distributors
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports